z-logo
Premium
Different tocolytics appear equally safe long‐term but we need both higher follow‐up rates and placebo‐controlled trials in future
Author(s) -
Thornton JG
Publication year - 2020
Publication title -
bjog: an international journal of obstetrics and gynaecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.157
H-Index - 164
eISSN - 1471-0528
pISSN - 1470-0328
DOI - 10.1111/1471-0528.16230
Subject(s) - nifedipine , medicine , placebo , odds ratio , tocolytic agent , pediatrics , odds , randomized controlled trial , pregnancy , obstetrics , logistic regression , gestation , preterm labor , alternative medicine , biology , genetics , calcium , pathology

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom